Ligand-independent homo- and heterodimerization of human prolactin receptor variants: Inhibitory action of the short forms by heterodimerization

Molecular Endocrinology

Volumn 20, Issue 8, 2006, Pages 1912-1923

  Qazi, Aamer M ^a   Tsai Morris, Chon Hwa ^a   Dufau, Maria L ^a,b  

^a EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^b NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AVIDIN; BIOTIN; CYSTEINE DERIVATIVE; HETERODIMER; HOMODIMER; JANUS KINASE 2; PROLACTIN; PROLACTIN RECEPTOR; STAT5 PROTEIN;

ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; BIOTINYLATION; CELL DIFFERENTIATION; CELL STRAIN HEK293; COMPLEX FORMATION; DIMERIZATION; ENZYME ACTIVATION; HORMONE ACTION; HUMAN; IMMUNOPRECIPITATION; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; SITE DIRECTED MUTAGENESIS;

ANTIGENS, SURFACE; CELLS, CULTURED; CYSTEINE; DIMERIZATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; GREEN FLUORESCENT PROTEINS; HUMANS; JANUS KINASE 2; LIGANDS; LUMINESCENT PROTEINS; MUTAGENESIS, SITE-DIRECTED; PEPTIDES; PROLACTIN; PROTEIN ISOFORMS; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, PROLACTIN; RECOMBINANT PROTEINS; TRANSFECTION;

EID: 33746606004     PISSN: 08888809     EISSN: 08888809     Source Type: Journal    
DOI: 10.1210/me.2005-0291     Document Type: Article

References (31)

1. Bole-Feysot C, Goffin V, Edery M, Binart N, Kelly PA 1998 Prolactin (PRL) and its receptor: actions, signal transduction pathways and phenotypes observed in PRL receptor knockout mice. Endocr Rev 19:225-268
2. Boutin JM, Edery M, Shirota M, Jolicoeur C, Lesueur L, Ali S, Gould D, Djiane J, Kelly PA 1989 Identification of a cDNA encoding a long form of prolactin receptor in human hepatoma and breast cancer cells. Mol Endocrinol 3:1455-1461
3. Hu ZZ, Zhuang L, Dufau ML 1998 Prolactin receptor diversity: structure and regulation. Trends Endocrinol Metab 9:94-1002
4. Hu ZZ, Zhuang L, Meng J, Leondires M, Dufau ML 1999 The human prolactin receptor gene structure and alternative promoter utilization: the generic promoter hPIII and a novel human promoter hP(N). J Clin Endocrinol Metab 84:1153-1156
5. Kline JB, Roehrs H, Clevenger CV 1999 Functional characterization of the intermediate isoform of the human prolactin receptor. J Biol Chem 274:35461-35468
6. Hu ZZ, Meng J, Dufau ML 2001 Isolation and characterization of two novel forms of the human prolactin receptor generated by alternative splicing of a newly identified exon 11. J Biol Chem 276:41086-41094
7. Hu ZZ, Zhuang L, Meng J, Tsai-Morris CH, Dufau ML 2002 Complex 5′ genomic structure of the human prolactin receptor: multiple alternative exons 1 and promoter utilization. Endocrinology 143:2139-2142
8. Finidori J, Kelly PA 1995 Cytokine receptor signalling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription. J Endocrinol 147:11-23
9. Ihle JN, Kerr IM 1995 Jaks and Stats in signaling by the cytokine receptor superfamily. Trends Genet 11:69-74
10. Pezet A, Ferrag F, Kelly PA, Edery M 1997 Tyrosine docking sites of the rat prolactin receptor required for association and activation of stat5. J Biol Chem 272:25043-25050
11. Ali S, Ali S 2000 Recruitment of the protein-tyrosine phosphatase SHP-2 to the C-terminal tyrosine of the prolactin receptor and to the adaptor protein Gab2. J Biol Chem 275:39073-39080
12. Wennbo H, Gebre-Medhin M, Gritli-Linde A, Ohlsson C, Isaksson OG, Tornell J 1997 Activation of the prolactin receptor but not the growth hormone receptor is important for induction of mammary tumors in transgenic mice. J Clin Invest 100:2744-2751
13. Touraine P, Martini JF, Zafrani B, Durand JC, Labaille F, Malet C, Nicolas A, Trivin C, Postel-Vinay MC, Kuttenn F, Kelly PA 1998 Increased expression of prolactin receptor gene assessed by quantitative polymerase chain reaction in human breast tumors versus normal breast tissues. J Clin Endocrinol Metab 83:667-674
14. Meng J, Tsai-Morris CH, Dufau ML 2004 Human prolactin receptor variants in breast cancer: low ratio of short forms to the long-form human prolactin receptor associated with mammary carcinoma. Cancer Res 64:5677-5682
15. Boger DL, Goldberg J 2001 Cytokine receptor dimerization and activation: prospects for small molecule agonists. Bioorg Med Chem 9:557-562
16. Frank SJ 2002 Receptor dimerization in GH and erythropoietin action-it takes two to tango, but how? Endocrinology 143:2-10
17. Kisseleva T, Bhattacharya S, Braunstein J, Schindler CW 2002 Signaling through the JAK/STAT pathway, recent advances and future challenges. Gene 285:1-24
18. Shen Q, Subauste JS 2000 Dimerization interfaces of verbA homodimers and heterodimers with retinoid X receptor α. J Biol Chem 275:41018-41027
19. Schlessinger J 2002 Ligand-induced, receptor-mediated dimerization and activation of EGF receptor. Cell 110:669-672
20. Klein P, Mattoon D, Lemmon MA, Schlessinger J 2004 A structure-based model for ligand binding and dimerization of EGF receptors. Proc Natl Acad Sci USA 101:929-934
21. Dawson JP, Berger MB, Lin CC, Schlessinger J, Lemmon MA, Ferguson KM 2005 Epidermal growth factor receptor dimerization and activation require ligand-induced conformational changes in the dimer interface. Mol Cell Biol 25:7734-7742
22. Livnah O, Stura EA, Middleton SA, Johnson DL, Jolliffe LK, Wilson IA 1999 Crystallographic evidence for preformed dimers of erythropoietin receptor before ligand activation. Science 283:987-990
23. Remy I, Wilson IA, Michnick SW 1999 Erythropoietin receptor activation by a ligand-induced conformation change. Science 283:990-993
24. Constantinescu SN, Keren T, Socolovsky M, Nam H, Henis YI, Lodish HF 2001 Ligand-independent oligomerization of cell-surface erythropoietin receptor is mediated by the transmembrane domain. Proc Natl Acad Sci USA 98:4379-4384
25. Gent J, van Kerkhof P, Roza M, Bu G, Strous GJ 2002 Ligand-independent growth hormone receptor dimerization occurs in the endoplasmic reticulum and is required for ubiquitin system-dependent endocytosis. Proc Natl Acad Sci USA 99:9858-9863
26. DaSilva L, Howard OM, Rui H, Kirken RA, Farrar WL 1994 Growth signaling and JAK2 association mediated by membrane-proximal cytoplasmic regions of prolactin receptors. J Biol Chem 269:18267-18270
27. Xu Y, Piston DW, Johnson CH 1999 A bioluminescence resonance energy transfer (BRET) system: application to interacting circadian clock proteins. Proc Natl Acad Sci USA 96:151-156
28. Bolander Jr FF, Ginsburg E, Vonderhaar BK 1997 The regulation of mammary prolactin receptor metabolism by a retroviral envelope protein. J Mol Endocrinol 19:131-136
29. Lebrun JJ, Ali S, Ullrich A, Kelly PA 1995 Proline-rich sequence-mediated Jak2 association to the prolactin receptor is required but not sufficient for signal transduction. J Biol Chem 270:10664-10670
30. Elkins PA, Christinger HW, Sandowski Y, Sakal E, Gertler A, de Vos AM, Kossiakoff AA 2000 Ternary complex between placental lactogen and the extracellular domain of the prolactin receptor. Nat Struct Biol 7:808-815
31. Perrot-Applanat M, Gualillo O, Pezet A, Vincent V, Edery M, Kelly PA 1997 Dominant-negative and cooperative effects of mutant forms of prolactin receptor. Mol Endocrinol 11:1020-1032